RE: More shares available to StormontIt just means that these shares were and are not free trading for Stormont until November 19th. Makes no difference as Stormont has more than enough that are currently free trading to follow through with their intention to sell three million more. The unknowns you mention are the reason your getting a $1 stock for under .20 right now. When news out of NCI meetings and details of Sloan Kettering relationship come out new buying will easily absorb Stormont shares and more. Have a look at the research area of the Sloan Kettering site. They much prefer to develop their own therapies and seldom offer resources to 3rd parties like PharmaGap...
https://www.mskcc.org/mskcc/html/14229.cfm
"Priority is placed on evaluating the in-house new compounds"
I like this fact, great place for GAP-107B8 to be...
Memorial Sloan-Kettering Cancer Center conducts one of the largest programs of clinical research in the world